Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial

Raygan, Fariba ; Ostadmohammadi, Vahidreza ; Bahmani, Fereshteh ; Reiter, Russel J. ; Asemi, Zatollah

Clinical nutrition (Edinburgh, Scotland), 2019-02, Vol.38 (1), p.191-196 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível